When Dr. Lawrence C.B. Chan and Dr. Vijay Yechoor of Baylor College of Medicine used a special gene therapy to induce the livers of mice with diabetes to make islet or beta cells, they knew they were ...
Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been ... reduction of haemoglobin A1c levels – a marker of blood glucose control – to 7% or ...
Case 1 suggests that ICA may be a transient marker of a persisting underlying ... indicate inevitable progression to total islet cell destruction and that cessation of immune islet cell ...
Nat Clin Pract Endocrinol Metab. 2006;2(5):240-241. Diabetes occurs when there is an inadequate functional mass of insulin-producing pancreatic β cells. Replacement of β cells by islet ...
The technology could be used to stop the body from rejecting transplanted organs and tissues, such as pancreatic islet cells, which are sometimes used to treat type 1 diabetes. That way, recipients ...
PDX-1 is a critically important transcription factor for the insulin promoter, is absent in glucotoxic islets, and, when transfected into glucotoxic ß-cells ... of elevated markers of oxidative ...
This includes examining genes, the initiation and progression of islet autoimmunity through autoantibodies (markers of future risk of developing type 1 diabetes), cellular immunity and other factors ...
The new approach could be used to stop the body from rejecting transplanted organs and tissues, such as pancreatic islet cells, which are sometimes used to treat type 1 diabetes. That way ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback